Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
NCT01974817
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
End Stage Renal Disease
Interventions
BIOLOGICAL:
13-valent conjugate pneumococcal vaccine
Sponsor
Michigan State University
Collaborators
[object Object]